Clinical Trial Update: The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients [NA]

View source ↗

Summary

The study evaluating sildenafil as an adjunct to antidepressants for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Sadat City University | Conditions: Major Depressive Disorder | NA | Status: WITHDRAWN